Medtronic (MDT) Liabilities and Shareholders Equity (2014 - 2026)

Medtronic has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $91.5 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $91.5 billion, up 1.68% year-over-year; the trailing twelve-month figure through Jan 2026 was $365.5 billion (up 1.6% YoY), and the FY2025 annual result was $91.7 billion, up 1.89% from the prior year.
• Liabilities and Shareholders Equity came in at $91.5 billion for Q1 2026 at Medtronic, roughly flat from $91.3 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $94.1 billion in Q1 2023 to a low of $89.7 billion in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $90.9 billion (2023), against an average of $91.1 billion.
• Across the five-year window, Liabilities and Shareholders Equity dropped 5.62% in 2022 and grew 2.54% in 2023, its largest moves.
• Medtronic's Liabilities and Shareholders Equity stood at $93.2 billion in 2022, then dropped by 3.38% to $90.1 billion in 2023, then fell by 0.05% to $90.0 billion in 2024, then advanced by 1.45% to $91.3 billion in 2025, then advanced by 0.15% to $91.5 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $91.5 billion (Q1 2026), $91.3 billion (Q4 2025), and $91.0 billion (Q3 2025), per Business Quant data.